{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:19:40Z","timestamp":1783441180074,"version":"3.54.6"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1053\/j.ajkd.2020.03.018","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T02:01:20Z","timestamp":1593741680000},"page":"308-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Calcimimetics: A Promise Unfulfilled"],"prefix":"10.1053","volume":"76","author":[{"given":"James B.","family":"Wetmore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1053\/j.ajkd.2020.03.018_bib1","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2020.03.018_bib2","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1053\/j.ajkd.2010.10.041","article-title":"Trends in parathyroidectomy rates in US hemodialysis patients from 1992 to 2007","volume":"57","author":"Li","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1053\/j.ajkd.2020.03.018_bib3","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.2215\/CJN.10370915","article-title":"Rates and outcomes of parathyroidectomy for secondary hyperparathyroidism in the United States","volume":"11","author":"Kim","year":"2016","journal-title":"Clin. J Am Soc Nephrol"},{"issue":"9 suppl 4","key":"10.1053\/j.ajkd.2020.03.018_bib4","doi-asserted-by":"crossref","first-page":"S310","DOI":"10.1097\/01.ASN.0000081666.10967.05","article-title":"Slowing the progression of vascular calcification in hemodialysis","volume":"14","author":"Chertow","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2020.03.018_bib5","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.018_bib6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ncpneph0977","article-title":"Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift?","volume":"5","author":"Wetmore","year":"2009","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1053\/j.ajkd.2020.03.018_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12882-015-0174-6","article-title":"Dynamics of cinacalcet use and biochemical control in hemodialysis patients: a retrospective new-user cohort design","volume":"16","author":"Reams","year":"2015","journal-title":"BMC Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2020.03.018_bib8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2016.19456","article-title":"Effect of etelcalcetide vs placebo on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism: two randomized clinical trials","volume":"317","author":"Block","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"10.1053\/j.ajkd.2020.03.018_bib9","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.kint.2018.05.013","article-title":"Evocalcet study group. Head-to-head comparison of the new calcimimetic agent evocalcet with cinacalcet in Japanese hemodialysis patients with secondary hyperparathyroidism","volume":"94","author":"Fukagawa","year":"2018","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2020.03.018_bib10","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1185\/03007995.2015.1031731","article-title":"A\u00a0randomized, double-blind, phase 2 study evaluating the safety and efficacy of AMG 416 for the treatment of secondary hyperparathyroidism in hemodialysis patients","volume":"31","author":"Bell","year":"2015","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"10.1053\/j.ajkd.2020.03.018_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/j.ajkd.2020.02.439","article-title":"Comparative effectiveness of calcimimetic agents for secondary hyperparathyroidism in adults: a systematic review and network meta-analysis","volume":"76","author":"Palmer","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2020.03.018_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001436","article-title":"Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials","volume":"10","author":"Palmer","year":"2013","journal-title":"PLoS Med"},{"issue":"2","key":"10.1053\/j.ajkd.2020.03.018_bib13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2016.19468","article-title":"Effect of etelcalcetide vs cinacalcet on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism: a randomized clinical trial","volume":"317","author":"Block","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"10.1053\/j.ajkd.2020.03.018_bib14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/hdi.12410","article-title":"Efficacy and safety of cinacalcet on secondary hyperparathyroidism in Chinese chronic kidney disease patients receiving hemodialysis","volume":"20","author":"Mei","year":"2016","journal-title":"Hemodial Int"},{"issue":"26","key":"10.1053\/j.ajkd.2020.03.018_bib15","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Chertow","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.018_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/ndt\/gfv291","article-title":"Changes in secondary hyperparathyroidism-related biochemical parameters and medication use following parathyroidectomy","volume":"31","author":"Wetmore","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.018_bib17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2215\/CJN.03520414","article-title":"Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis","volume":"10","author":"Ishani","year":"2015","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638620307125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638620307125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:29:01Z","timestamp":1759462141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638620307125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0272638620307125"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2020.03.018","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calcimimetics: A Promise Unfulfilled","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2020.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2020.02.439","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}